Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 366

1.

Generation of functional human hepatocytes in vitro: current status and future prospects.

Yamaguchi T, Matsuzaki J, Katsuda T, Saito Y, Saito H, Ochiya T.

Inflamm Regen. 2019 Jul 2;39:13. doi: 10.1186/s41232-019-0102-4. eCollection 2019. Review.

PMID:
31308858
Free Article
2.

Single-cell Analysis Reveals a Preexisting Drug-Resistant Subpopulation in the Luminal Breast Cancer Subtype.

Prieto-Vila M, Usuba W, Takahashi RU, Shimomura I, Sasaki H, Ochiya T, Yamamoto Y.

Cancer Res. 2019 Jul 9. pii: canres.0122.2019. doi: 10.1158/0008-5472.CAN-19-0122. [Epub ahead of print]

PMID:
31289135
3.

Genetic manipulation of autonomic nerve fiber innervation and activity and its effect on breast cancer progression.

Kamiya A, Hayama Y, Kato S, Shimomura A, Shimomura T, Irie K, Kaneko R, Yanagawa Y, Kobayashi K, Ochiya T.

Nat Neurosci. 2019 Jul 8. doi: 10.1038/s41593-019-0430-3. [Epub ahead of print]

PMID:
31285612
4.

Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017.

Clayton A, Buschmann D, Byrd JB, Carter DRF, Cheng L, Compton C, Daaboul G, Devitt A, Falcon-Perez JM, Gardiner C, Gustafson D, Harrison P, Helmbrecht C, Hendrix A, Hill A, Hoffman A, Jones JC, Kalluri R, Kang JY, Kirchner B, Lässer C, Lawson C, Lenassi M, Levin C, Llorente A, Martens-Uzunova ES, Möller A, Musante L, Ochiya T, Pink RC, Tahara H, Wauben MHM, Webber JP, Welsh JA, Witwer KW, Yin H, Nieuwland R.

J Extracell Vesicles. 2018 May 17;7(1):1473707. doi: 10.1080/20013078.2018.1473707. eCollection 2018.

5.

Cancer extracellular vesicles contribute to stromal heterogeneity by inducing chemokines in cancer-associated fibroblasts.

Naito Y, Yamamoto Y, Sakamoto N, Shimomura I, Kogure A, Kumazaki M, Yokoi A, Yashiro M, Kiyono T, Yanagihara K, Takahashi RU, Hirakawa K, Yasui W, Ochiya T.

Oncogene. 2019 Jul;38(28):5566-5579. doi: 10.1038/s41388-019-0832-4. Epub 2019 May 30.

PMID:
31147602
6.

Serum MicroRNA-Based Risk Prediction for Stroke.

Sonoda T, Matsuzaki J, Yamamoto Y, Sakurai T, Aoki Y, Takizawa S, Niida S, Ochiya T.

Stroke. 2019 Jun;50(6):1510-1518. doi: 10.1161/STROKEAHA.118.023648. Epub 2019 Apr 15.

PMID:
31136284
7.

Involvement of Extracellular Vesicles in Vascular-Related Functions in Cancer Progression and Metastasis.

Kikuchi S, Yoshioka Y, Prieto-Vila M, Ochiya T.

Int J Mol Sci. 2019 May 26;20(10). pii: E2584. doi: 10.3390/ijms20102584. Review.

8.

Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA Profiling.

Sudo K, Kato K, Matsuzaki J, Boku N, Abe S, Saito Y, Daiko H, Takizawa S, Aoki Y, Sakamoto H, Niida S, Takeshita F, Fukuda T, Ochiya T.

JAMA Netw Open. 2019 May 3;2(5):e194573. doi: 10.1001/jamanetworkopen.2019.4573.

PMID:
31125107
9.

Usefulness of serum microRNA as a predictive marker of recurrence and prognosis in biliary tract cancer after radical surgery.

Akazawa Y, Mizuno S, Fujinami N, Suzuki T, Yoshioka Y, Ochiya T, Nakamoto Y, Nakatsura T.

Sci Rep. 2019 Apr 11;9(1):5925. doi: 10.1038/s41598-019-42392-7.

10.

An Insight into the Roles of MicroRNAs and Exosomes in Sarcoma.

Kohama I, Kosaka N, Chikuda H, Ochiya T.

Cancers (Basel). 2019 Mar 26;11(3). pii: E428. doi: 10.3390/cancers11030428. Review.

11.
12.

A serum microRNA classifier for the diagnosis of sarcomas of various histological subtypes.

Asano N, Matsuzaki J, Ichikawa M, Kawauchi J, Takizawa S, Aoki Y, Sakamoto H, Yoshida A, Kobayashi E, Tanzawa Y, Nakayama R, Morioka H, Matsumoto M, Nakamura M, Kondo T, Kato K, Tsuchiya N, Kawai A, Ochiya T.

Nat Commun. 2019 Mar 21;10(1):1299. doi: 10.1038/s41467-019-09143-8.

13.

Exploiting the message from cancer: the diagnostic value of extracellular vesicles for clinical applications.

Kosaka N, Kogure A, Yamamoto T, Urabe F, Usuba W, Prieto-Vila M, Ochiya T.

Exp Mol Med. 2019 Mar 15;51(3):31. doi: 10.1038/s12276-019-0219-1. Review.

14.

Synthetic Lethality in Lung Cancer-From the Perspective of Cancer Genomics.

Shimomura I, Yamamoto Y, Ochiya T.

Medicines (Basel). 2019 Mar 12;6(1). pii: E38. doi: 10.3390/medicines6010038. Review.

15.

Drug library screen reveals benzimidazole derivatives as selective cytotoxic agents for KRAS-mutant lung cancer.

Shimomura I, Yokoi A, Kohama I, Kumazaki M, Tada Y, Tatsumi K, Ochiya T, Yamamoto Y.

Cancer Lett. 2019 Jun 1;451:11-22. doi: 10.1016/j.canlet.2019.03.002. Epub 2019 Mar 9.

PMID:
30862488
16.

The antiviral effects of human microRNA miR-302c-3p against hepatitis B virus infection.

Hamada-Tsutsumi S, Naito Y, Sato S, Takaoka A, Kawashima K, Isogawa M, Ochiya T, Tanaka Y.

Aliment Pharmacol Ther. 2019 Apr;49(8):1060-1070. doi: 10.1111/apt.15197. Epub 2019 Mar 3.

PMID:
30828831
17.

Risk prediction models for dementia constructed by supervised principal component analysis using miRNA expression data.

Shigemizu D, Akiyama S, Asanomi Y, Boroevich KA, Sharma A, Tsunoda T, Matsukuma K, Ichikawa M, Sudo H, Takizawa S, Sakurai T, Ozaki K, Ochiya T, Niida S.

Commun Biol. 2019 Feb 25;2:77. doi: 10.1038/s42003-019-0324-7. eCollection 2019.

18.

Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer.

Urabe F, Matsuzaki J, Yamamoto Y, Kimura T, Hara T, Ichikawa M, Takizawa S, Aoki Y, Niida S, Sakamoto H, Kato K, Egawa S, Fujimoto H, Ochiya T.

Clin Cancer Res. 2019 May 15;25(10):3016-3025. doi: 10.1158/1078-0432.CCR-18-2849. Epub 2019 Feb 26.

PMID:
30808771
19.

Development of miRNA-based therapeutic approaches for cancer patients.

Takahashi RU, Prieto-Vila M, Kohama I, Ochiya T.

Cancer Sci. 2019 Apr;110(4):1140-1147. doi: 10.1111/cas.13965. Epub 2019 Feb 26. Review.

20.

Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.

Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F, Atkin-Smith GK, Ayre DC, Bach JM, Bachurski D, Baharvand H, Balaj L, Baldacchino S, Bauer NN, Baxter AA, Bebawy M, Beckham C, Bedina Zavec A, Benmoussa A, Berardi AC, Bergese P, Bielska E, Blenkiron C, Bobis-Wozowicz S, Boilard E, Boireau W, Bongiovanni A, Borràs FE, Bosch S, Boulanger CM, Breakefield X, Breglio AM, Brennan MÁ, Brigstock DR, Brisson A, Broekman ML, Bromberg JF, Bryl-Górecka P, Buch S, Buck AH, Burger D, Busatto S, Buschmann D, Bussolati B, Buzás EI, Byrd JB, Camussi G, Carter DR, Caruso S, Chamley LW, Chang YT, Chen C, Chen S, Cheng L, Chin AR, Clayton A, Clerici SP, Cocks A, Cocucci E, Coffey RJ, Cordeiro-da-Silva A, Couch Y, Coumans FA, Coyle B, Crescitelli R, Criado MF, D'Souza-Schorey C, Das S, Datta Chaudhuri A, de Candia P, De Santana EF, De Wever O, Del Portillo HA, Demaret T, Deville S, Devitt A, Dhondt B, Di Vizio D, Dieterich LC, Dolo V, Dominguez Rubio AP, Dominici M, Dourado MR, Driedonks TA, Duarte FV, Duncan HM, Eichenberger RM, Ekström K, El Andaloussi S, Elie-Caille C, Erdbrügger U, Falcón-Pérez JM, Fatima F, Fish JE, Flores-Bellver M, Försönits A, Frelet-Barrand A, Fricke F, Fuhrmann G, Gabrielsson S, Gámez-Valero A, Gardiner C, Gärtner K, Gaudin R, Gho YS, Giebel B, Gilbert C, Gimona M, Giusti I, Goberdhan DC, Görgens A, Gorski SM, Greening DW, Gross JC, Gualerzi A, Gupta GN, Gustafson D, Handberg A, Haraszti RA, Harrison P, Hegyesi H, Hendrix A, Hill AF, Hochberg FH, Hoffmann KF, Holder B, Holthofer H, Hosseinkhani B, Hu G, Huang Y, Huber V, Hunt S, Ibrahim AG, Ikezu T, Inal JM, Isin M, Ivanova A, Jackson HK, Jacobsen S, Jay SM, Jayachandran M, Jenster G, Jiang L, Johnson SM, Jones JC, Jong A, Jovanovic-Talisman T, Jung S, Kalluri R, Kano SI, Kaur S, Kawamura Y, Keller ET, Khamari D, Khomyakova E, Khvorova A, Kierulf P, Kim KP, Kislinger T, Klingeborn M, Klinke DJ 2nd, Kornek M, Kosanović MM, Kovács ÁF, Krämer-Albers EM, Krasemann S, Krause M, Kurochkin IV, Kusuma GD, Kuypers S, Laitinen S, Langevin SM, Languino LR, Lannigan J, Lässer C, Laurent LC, Lavieu G, Lázaro-Ibáñez E, Le Lay S, Lee MS, Lee YXF, Lemos DS, Lenassi M, Leszczynska A, Li IT, Liao K, Libregts SF, Ligeti E, Lim R, Lim SK, Linē A, Linnemannstöns K, Llorente A, Lombard CA, Lorenowicz MJ, Lörincz ÁM, Lötvall J, Lovett J, Lowry MC, Loyer X, Lu Q, Lukomska B, Lunavat TR, Maas SL, Malhi H, Marcilla A, Mariani J, Mariscal J, Martens-Uzunova ES, Martin-Jaular L, Martinez MC, Martins VR, Mathieu M, Mathivanan S, Maugeri M, McGinnis LK, McVey MJ, Meckes DG Jr, Meehan KL, Mertens I, Minciacchi VR, Möller A, Møller Jørgensen M, Morales-Kastresana A, Morhayim J, Mullier F, Muraca M, Musante L, Mussack V, Muth DC, Myburgh KH, Najrana T, Nawaz M, Nazarenko I, Nejsum P, Neri C, Neri T, Nieuwland R, Nimrichter L, Nolan JP, Nolte-'t Hoen EN, Noren Hooten N, O'Driscoll L, O'Grady T, O'Loghlen A, Ochiya T, Olivier M, Ortiz A, Ortiz LA, Osteikoetxea X, Østergaard O, Ostrowski M, Park J, Pegtel DM, Peinado H, Perut F, Pfaffl MW, Phinney DG, Pieters BC, Pink RC, Pisetsky DS, Pogge von Strandmann E, Polakovicova I, Poon IK, Powell BH, Prada I, Pulliam L, Quesenberry P, Radeghieri A, Raffai RL, Raimondo S, Rak J, Ramirez MI, Raposo G, Rayyan MS, Regev-Rudzki N, Ricklefs FL, Robbins PD, Roberts DD, Rodrigues SC, Rohde E, Rome S, Rouschop KM, Rughetti A, Russell AE, Saá P, Sahoo S, Salas-Huenuleo E, Sánchez C, Saugstad JA, Saul MJ, Schiffelers RM, Schneider R, Schøyen TH, Scott A, Shahaj E, Sharma S, Shatnyeva O, Shekari F, Shelke GV, Shetty AK, Shiba K, Siljander PR, Silva AM, Skowronek A, Snyder OL 2nd, Soares RP, Sódar BW, Soekmadji C, Sotillo J, Stahl PD, Stoorvogel W, Stott SL, Strasser EF, Swift S, Tahara H, Tewari M, Timms K, Tiwari S, Tixeira R, Tkach M, Toh WS, Tomasini R, Torrecilhas AC, Tosar JP, Toxavidis V, Urbanelli L, Vader P, van Balkom BW, van der Grein SG, Van Deun J, van Herwijnen MJ, Van Keuren-Jensen K, van Niel G, van Royen ME, van Wijnen AJ, Vasconcelos MH, Vechetti IJ Jr, Veit TD, Vella LJ, Velot É, Verweij FJ, Vestad B, Viñas JL, Visnovitz T, Vukman KV, Wahlgren J, Watson DC, Wauben MH, Weaver A, Webber JP, Weber V, Wehman AM, Weiss DJ, Welsh JA, Wendt S, Wheelock AM, Wiener Z, Witte L, Wolfram J, Xagorari A, Xander P, Xu J, Yan X, Yáñez-Mó M, Yin H, Yuana Y, Zappulli V, Zarubova J, Žėkas V, Zhang JY, Zhao Z, Zheng L, Zheutlin AR, Zickler AM, Zimmermann P, Zivkovic AM, Zocco D, Zuba-Surma EK.

J Extracell Vesicles. 2018 Nov 23;7(1):1535750. doi: 10.1080/20013078.2018.1535750. eCollection 2018.

21.

Cross-talk between cancer cells and their neighbors via miRNA in extracellular vesicles: an emerging player in cancer metastasis.

Kogure A, Kosaka N, Ochiya T.

J Biomed Sci. 2019 Jan 12;26(1):7. doi: 10.1186/s12929-019-0500-6. Review.

22.

Generation of Hepatic Organoids with Biliary Structures.

Katsuda T, Ochiya T, Sakai Y.

Methods Mol Biol. 2019;1905:175-185. doi: 10.1007/978-1-4939-8961-4_16.

PMID:
30536100
23.

Chemically Induced Liver Progenitors (CLiPs): A Novel Cell Source for Hepatocytes and Biliary Epithelial Cells.

Katsuda T, Ochiya T.

Methods Mol Biol. 2019;1905:117-130. doi: 10.1007/978-1-4939-8961-4_11.

PMID:
30536095
24.

Serum miRNA-based Prediction of Axillary Lymph Node Metastasis in Breast Cancer.

Shiino S, Matsuzaki J, Shimomura A, Kawauchi J, Takizawa S, Sakamoto H, Aoki Y, Yoshida M, Tamura K, Kato K, Kinoshita T, Kitagawa Y, Ochiya T.

Clin Cancer Res. 2019 Mar 15;25(6):1817-1827. doi: 10.1158/1078-0432.CCR-18-1414. Epub 2018 Nov 27.

PMID:
30482779
25.

Pazopanib-induced changes in protein expression signatures of extracellular vesicles in synovial sarcoma.

Shiozawa K, Yoshioka Y, Qiao Z, Shuting J, Ochiya T, Kondo T.

Biochem Biophys Res Commun. 2018 Nov 30;506(3):723-730. doi: 10.1016/j.bbrc.2018.10.012. Epub 2018 Oct 27.

PMID:
30454707
26.

Circulating miRNA panels for specific and early detection in bladder cancer.

Usuba W, Urabe F, Yamamoto Y, Matsuzaki J, Sasaki H, Ichikawa M, Takizawa S, Aoki Y, Niida S, Kato K, Egawa S, Chikaraishi T, Fujimoto H, Ochiya T.

Cancer Sci. 2019 Jan;110(1):408-419. doi: 10.1111/cas.13856. Epub 2018 Dec 12.

27.

Integrated extracellular microRNA profiling for ovarian cancer screening.

Yokoi A, Matsuzaki J, Yamamoto Y, Yoneoka Y, Takahashi K, Shimizu H, Uehara T, Ishikawa M, Ikeda SI, Sonoda T, Kawauchi J, Takizawa S, Aoki Y, Niida S, Sakamoto H, Kato K, Kato T, Ochiya T.

Nat Commun. 2018 Oct 17;9(1):4319. doi: 10.1038/s41467-018-06434-4.

28.

Clinical Application of Mesenchymal Stem Cell-Derived Extracellular Vesicle-Based Therapeutics for Inflammatory Lung Diseases.

Fujita Y, Kadota T, Araya J, Ochiya T, Kuwano K.

J Clin Med. 2018 Oct 14;7(10). pii: E355. doi: 10.3390/jcm7100355. Review.

29.

UBL3 modification influences protein sorting to small extracellular vesicles.

Ageta H, Ageta-Ishihara N, Hitachi K, Karayel O, Onouchi T, Yamaguchi H, Kahyo T, Hatanaka K, Ikegami K, Yoshioka Y, Nakamura K, Kosaka N, Nakatani M, Uezumi A, Ide T, Tsutsumi Y, Sugimura H, Kinoshita M, Ochiya T, Mann M, Setou M, Tsuchida K.

Nat Commun. 2018 Sep 26;9(1):3936. doi: 10.1038/s41467-018-06197-y.

30.

Extracellular vesicles and encapusulated miRNAs as emerging cancer biomarkers for novel liquid biopsy.

Yoshioka Y, Katsuda T, Ochiya T.

Jpn J Clin Oncol. 2018 Oct 1;48(10):869-876. doi: 10.1093/jjco/hyy120. Review.

PMID:
30169666
31.

Extracellular microRNAs and oxidative stress in liver injury: a systematic mini review.

Matsuzaki J, Ochiya T.

J Clin Biochem Nutr. 2018 Jul;63(1):6-11. doi: 10.3164/jcbn.17-123. Epub 2018 Apr 11. Review.

32.

Fascin protein stabilization by miR-146a implicated in the process of a chronic inflammation-related colon carcinogenesis model.

Kanda Y, Kawaguchi T, Osaki M, Onuma K, Ochiya T, Kitagawa T, Okada F.

Inflamm Res. 2018 Oct;67(10):839-846. doi: 10.1007/s00011-018-1175-2. Epub 2018 Jul 28.

PMID:
30056535
33.

A Nucleolar Stress-Specific p53-miR-101 Molecular Circuit Functions as an Intrinsic Tumor-Suppressor Network.

Fujiwara Y, Saito M, Robles AI, Nishida M, Takeshita F, Watanabe M, Ochiya T, Yokota J, Kohno T, Harris CC, Tsuchiya N.

EBioMedicine. 2018 Jul;33:33-48. doi: 10.1016/j.ebiom.2018.06.031. Epub 2018 Jul 7.

34.

Screening of microRNAs for a repressor of hepatitis B virus replication.

Naito Y, Hamada-Tsutsumi S, Yamamoto Y, Kogure A, Yoshioka Y, Watashi K, Ochiya T, Tanaka Y.

Oncotarget. 2018 Jul 6;9(52):29857-29868. doi: 10.18632/oncotarget.25557. eCollection 2018 Jul 6.

35.

[MicroRNA in Body Fluids - Development of the Novel Plat Form for Cancer Therapeutics and Diagnosis].

Takahashi RU, Prieto-Vila M, Kohama I, Ochiya T.

Gan To Kagaku Ryoho. 2018 Jun;45(6):899-905. Japanese.

PMID:
30026410
36.

Regulatory role of resveratrol, a microRNA-controlling compound, in HNRNPA1 expression, which is associated with poor prognosis in breast cancer.

Otsuka K, Yamamoto Y, Ochiya T.

Oncotarget. 2018 May 15;9(37):24718-24730. doi: 10.18632/oncotarget.25339. eCollection 2018 May 15.

37.

Emerging roles of long non-coding RNA in cancer.

Sanchez Calle A, Kawamura Y, Yamamoto Y, Takeshita F, Ochiya T.

Cancer Sci. 2018 Jul;109(7):2093-2100. doi: 10.1111/cas.13642. Epub 2018 Jun 28. Review.

38.

The p53 activator overcomes resistance to ALK inhibitors by regulating p53-target selectivity in ALK-driven neuroblastomas.

Miyazaki M, Otomo R, Matsushima-Hibiya Y, Suzuki H, Nakajima A, Abe N, Tomiyama A, Ichimura K, Matsuda K, Watanabe T, Ochiya T, Nakagama H, Sakai R, Enari M.

Cell Death Discov. 2018 May 10;4:56. doi: 10.1038/s41420-018-0059-0. eCollection 2018.

39.

Differentiation Therapy by Epigenetic Reconditioning Exerts Antitumor Effects on Liver Cancer Cells.

Gailhouste L, Liew LC, Yasukawa K, Hatada I, Tanaka Y, Nakagama H, Ochiya T.

Mol Ther. 2018 Jul 5;26(7):1840-1854. doi: 10.1016/j.ymthe.2018.04.018. Epub 2018 Apr 26.

40.

Extracellular vesicles: Toward a clinical application in urological cancer treatment.

Urabe F, Kosaka N, Kimura T, Egawa S, Ochiya T.

Int J Urol. 2018 Jun;25(6):533-543. doi: 10.1111/iju.13594. Epub 2018 May 3. Review.

41.

Imaging of angiogenesis of human umbilical vein endothelial cells by uptake of exosomes secreted from hepatocellular carcinoma cells.

Yukawa H, Suzuki K, Aoki K, Arimoto T, Yasui T, Kaji N, Ishikawa T, Ochiya T, Baba Y.

Sci Rep. 2018 Apr 30;8(1):6765. doi: 10.1038/s41598-018-24563-0.

42.

Epigenetic reprogramming using 5-azacytidine promotes an anti-cancer response in pancreatic adenocarcinoma cells.

Gailhouste L, Liew LC, Hatada I, Nakagama H, Ochiya T.

Cell Death Dis. 2018 May 1;9(5):468. doi: 10.1038/s41419-018-0487-z.

43.

Epigenetic Reprogramming of Human Hepatoma Cells: A Low-Cost Option for Drug Metabolism Assessment.

Gailhouste L, Liew LC, Yasukawa K, Hagiwara K, Iwazaki N, Yamada Y, Hatada I, Ochiya T.

Cell Mol Gastroenterol Hepatol. 2017 Nov 22;5(3):454-457.e1. doi: 10.1016/j.jcmgh.2017.11.006. eCollection 2018 Mar. No abstract available.

44.
45.

CD44 exerts a functional role during EMT induction in cisplatin-resistant head and neck cancer cells.

Miyazaki H, Takahashi RU, Prieto-Vila M, Kawamura Y, Kondo S, Shirota T, Ochiya T.

Oncotarget. 2018 Jan 13;9(11):10029-10041. doi: 10.18632/oncotarget.24252. eCollection 2018 Feb 9.

46.

Biocompatibility of highly purified bovine milk-derived extracellular vesicles.

Somiya M, Yoshioka Y, Ochiya T.

J Extracell Vesicles. 2018 Feb 21;7(1):1440132. doi: 10.1080/20013078.2018.1440132. eCollection 2018.

47.

Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A.

Hashimoto K, Ochi H, Sunamura S, Kosaka N, Mabuchi Y, Fukuda T, Yao K, Kanda H, Ae K, Okawa A, Akazawa C, Ochiya T, Futakuchi M, Takeda S, Sato S.

Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):2204-2209. doi: 10.1073/pnas.1717363115. Epub 2018 Feb 12.

48.

Unveiling massive numbers of cancer-related urinary-microRNA candidates via nanowires.

Yasui T, Yanagida T, Ito S, Konakade Y, Takeshita D, Naganawa T, Nagashima K, Shimada T, Kaji N, Nakamura Y, Thiodorus IA, He Y, Rahong S, Kanai M, Yukawa H, Ochiya T, Kawai T, Baba Y.

Sci Adv. 2017 Dec 15;3(12):e1701133. doi: 10.1126/sciadv.1701133. eCollection 2017 Dec.

49.

[The biological role of exosomes in bone remodeling and bone diseases.]

Urabe F, Yoshioka Y, Ochiya T.

Clin Calcium. 2018;28(1):122-127. doi: CliCa1801122127. Japanese.

PMID:
29279437
50.

Epithelial stem cell culture: modeling human disease and applications for regenerative medicine.

Yamamoto Y, Ochiya T.

Inflamm Regen. 2017 Feb 6;37:3. doi: 10.1186/s41232-017-0034-9. eCollection 2017. Review.

Supplemental Content

Loading ...
Support Center